Latest clinical trials News | Page 6

Detecting Parkinson’s disease decades before symptoms appear
What is the OMAD diet? Is one meal a day actually good for weight loss? And is it safe?
Cerebral palsy community consulted over stem cell treatment
Fibre boost could combat ‘chemo brain’ drain
Funding boost for Curtin health innovators
US FDA grants Orphan Drug Designation for Noxopharm’s CRO-67
Vaccine via the nasal passage could be the new line of defence against Strep A
WHO recommends R21/Matrix-M vaccine for malaria prevention in updated advice on immunization
New research hub to fight heart disease opens in Sydney’s southwest
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type…
Funding better future for preterm babies
NIH Center grant bolsters male contraceptive research
Cairns Health Innovation Centre project moves to next phase
Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01…
Study links obesity and sleep
Lots of women try herbs like black cohosh for menopausal symptoms like hot flushes – but does it work?
Enhertu recommended for approval in the EU by CHMP for patients with HER2-mutant advanced non-small cell lung cancer
Global recognition for biomedical innovator
Possible migraine medication set to be trialled at UniSC Clinical Trials
Is it really safe to feed your cat a vegan diet?
New discovery for treatment of primary liver cancer
Top researchers meet to make cancer history
What can you do to speed up your metabolism?
Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)
Top Perth blood cancer researcher wins prestigious award
Datopotamab deruxtecan plus Imfinzi showed promising clinical activity in the first-line advanced non-small cell lung cancer setting in TROPION-Lung04 Phase Ib trial
Covid vaccine safety report – 07-09-2023
UniSC to trial potential new treatment for coeliac disease
Young Burleigh Heads prostate cancer survivor on mission to save lives
Emyria announces capital raise to progress mental healthcare programs
Non-animal models could deliver $1.5B growth
Calquence approved in China for chronic lymphocytic leukaemia
Blood Cancer Awareness Month – Drew observes hospital life
Using AI to develop more effective cancer treatment
Pharmaxis announces the publication of positive preclinical data for PXS-5505
Evaluation of MRFF’s Clinical Trials Activity initiative released
Bipolar disorder isn’t the same for everyone. So people should have more say in how they’re treated
We won’t always have to use animals for medical research. Here’s what we can do instead
Drug that targets scar-like tissue in tumours shows promise for pancreatic cancer
New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch
ANZUP and The George Institute join forces to shed light on prostate cancer treatments
Drug that targets scar-like tissue in tumours shows promise
WHO initiative signs new licensing agreements on COVID-19 technologies
Transcranial magnetic stimulation can treat depression. Developing research suggests it could also help autism, ADHD and OCD
WHO launches a global stakeholder survey on solutions for strengthening clinical trial infrastructure and capacity
Lynparza plus abiraterone approved in Japan for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
Opthea announces placement and fully underwritten entitlement offer to raise $80m
Covid vaccine safety report – 24-08-2023